1.Youdim, KA & Joseph, JA (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30, 583–594.
2.Youdim, KA, Spencer, JPE, Schroeter, H & Rice-Evans, C (2002) Dietary flavonoids as potential neuroprotectants. Biol Chem 383, 503–519.
3.Galli, RL, Shukitt-Hale, B, Youdim, KA & Joseph, JA (2002) Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann NY Acad Sci 959, 128–132.
4.Unno, K, Takabayashi, F, Kishido, T & Oku, N (2004) Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 39, 1027–1034.
5.Haque, AM, Hashimoto, M, Katakura, M, Tanabe, Y, Hara, Y & Shido, O (2006) Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 136, 1043–1047.
6.Kuriyama, S, Hozawa, A, Ohmori, K, Shimazu, T, Matsui, T, Ebihara, S, Awata, S, Nagatomi, R, Arai, H & Tsuji, I (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 83, 355–361.
7.Wang, Y, Wang, L, Wu, J & Cai, J (2006) The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. Br J Pharmacol 148, 147–153.
8.Inanami, O, Watanabe, Y, Syuto, B, Nakano, M, Tsuji, M & Kuwabara, M (1998) Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radic Res 29, 359–365.
9.Luo, Y, Smith, JV, Paramasivam, V, Burdick, A, Curry, KJ, Buford, JP, Khan, I, Netzer, WJ, Xu, H & Butko, P (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 99, 12197–12202.
10.Bastianetto, S, Zheng, WH & Quirion, R (2000) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74, 2268–2277.
11.Zimmermann, M, Colciaghi, F, Cattabeni, F & Di Luca, M (2002) Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol (Noisy-le-grand) 48, 613–623.
12.Datla, KP, Christidou, M, Widmer, WW, Rooprai, HK & Dexter, DT (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 12, 3871–3875.
13.Rice-Evans, CA, Miller, NJ & Paganga, G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20, 933–956.
14.Pollard, SE, Kuhnle, GG, Vauzour, D, Vafeiadou, K, Tzounis, X, Whiteman, M, Rice-Evans, C & Spencer, JPE (2006) The reaction of flavonoid metabolites with peroxynitrite. Biochem Biophys Res Commun 350, 960–968.
15.Williams, RJ, Spencer, JPE & Rice-Evans, C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838–849.
16.Spencer, JPE, Rice-Evans, C & Williams, RJ (2003) Modulation of pro-survival Akt/PKB & ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278, 34783–34793.
17.Schroeter, H, Boyd, C, Spencer, JPE, Williams, RJ, Cadenas, E & Rice-Evans, C (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23, 861–880.
18.Manach, C, Scalbert, A, Morand, C, Remesy, C & Jimenez, L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727–747.
19.Rice-Evans, C (2001) Flavonoid antioxidants. Curr Med Chem 8, 797–807.
20.Rice-Evans, C (1995) Plant polyphenols: free radical scavengers or chain-breaking antioxidants? Biochem Soc Symp 61, 103–116.
21.Spencer, JPE, Schroeter, H, Rechner, AR & Rice-Evans, C (2001) Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 3, 1023–1039.
22.Spencer, JPE, Abd El Mohsen, MM, Minihane, AM & Mathers, JC (2007) Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr 1–11.
23.Spencer, JPE, Chowrimootoo, G, Choudhury, R, Debnam, ES, Srai, SK & Rice-Evans, C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224–230.
24.Spencer, JPE (2003) Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 133, 3255S–3261S.
25.Scheline, RR (1999) Metabolism of oxygen heterocyclic compounds. CRC Handbook of Mammalian Metabolism of Plant Compounds, pp. 243–295 Boca Raton, FL: CRC Press Inc.
26.Spencer, JPE, Kuhnle, GG, Williams, RJ & Rice-Evans, C (2003) Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 372, 173–181.
27.Spencer, JPE, Schroeter, H, Crossthwaithe, AJ, Kuhnle, G, Williams, RJ & Rice-Evans, C (2001) Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic Biol Med 31, 1139–1146.
28.Miyake, Y, Shimoi, K, Kumazawa, S, Yamamoto, K, Kinae, N & Osawa, T (2000) Identification and antioxidant activity of flavonoid metabolites in plasma and urine of eriocitrin-treated rats. J Agric Food Chem 48, 3217–3224.
29.Terao, J, Yamaguchi, S, Shirai, M, Miyoshi, M, Moon, JH, Oshima, S, Inakuma, T, Tsushida, T & Kato, Y (2001) Protection by quercetin and quercetin 3-O-beta-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res 35, 925–931.
30.Shirai, M, Moon, JH, Tsushida, T & Terao, J (2001) Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. J Agric Food Chem 49, 5602–5608.
31.Yamamoto, N, Moon, JH, Tsushida, T, Nagao, A & Terao, J (1999) Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys 372, 347–354.
32.da Silva, EL, Piskula, MK, Yamamoto, N, Moon, JH & Terao, J (1998) Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 430, 405–408.
33.Letenneur, L, Proust-Lima, C, Le Gouge, A, Dartigues, JF & Barberger-Gateau, P (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165, 1364–1371.
34.Ho, SC, Chan, AS, Ho, YP, So, EK, Sham, A, Zee, B & Woo, JL (2007) Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 14, 489–499.
35.Lee, YB, Lee, HJ & Sohn, HS (2005) Soy isoflavones and cognitive function. J Nutr Biochem 16, 641–649.
36.File, SE, Jarrett, N, Fluck, E, Duffy, R, Casey, K & Wiseman, H (2001) Eating soya improves human memory. Psychopharmacology (Berl) 157, 430–436.
37.Kim, H, Xia, H, Li, L & Gewin, J (2000) Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy. Biofactors 12, 243–250.
38.Birge, SJ (1996) Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44, 865–870.
39.Henderson, VW (2006) Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138, 1031–1039.
40.Casini, ML, Marelli, G, Papaleo, E, Ferrari, A, D'Ambrosio, F & Unfer, V (2006) Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril 85, 972–978.
41.Kritz-Silverstein, D, Von, Mühlen D, Barrett-Connor, E & Bressel, MA (2003) Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 10, 196–202.
42.File, SE, Hartley, DE, Elsabagh, S, Duffy, R & Wiseman, H (2005) Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause 12, 193–201.
43.Zippel, R, Balestrini, M, Lomazzi, M & Sturani, E (2000) Calcium and calmodulin are essential for Ras-GRF1-mediated activation of the Ras pathway by lysophosphatidic acid. Exp Cell Res 258, 403–408.
44.Kreijkamp-Kaspers, S, Kok, L, Grobbee, DE, de Haan, EH, Aleman, A, Lampe, JW & van der Schouw, YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292, 65–74.
45.Fournier, LR, Ryan Borchers, TA, Robison, LM, Wiediger, M, Park, JS, Chew, BP, McGuire, MK, Sclar, DA, Skaer, TL & Beerman, KA (2007) The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging 11, 155–164.
46.Kreijkamp-Kaspers, S, Kok, L, Grobbee, DE, de Haan, EH, Aleman, A & van der Schouw, YT (2007) Dietary phytoestrogen intake and cognitive function in older women. J Gerontol A Biol Sci Med Sci 62, 556–562.
47.Barnes, S, Boersma, B, Patel, R, Kirk, M, Darley-Usmar, VM, Kim, H & Xu, J (2000) Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12, 209–215.
48.Kim, H, Peterson, TG & Barnes, S (1998) Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68, 1418S–1425S.
49.Schroeter, H, Heiss, C, Balzer, J, Kleinbongard, P, Keen, CL, Hollenberg, NK, Sies, H, Kwik-Uribe, C, Schmitz, HH & Kelm, M (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024–1029.
50.Francis, ST, Head, K, Morris, PG & Macdonald, IA (2006) The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215–S220.
51.Fisher, ND, Sorond, FA & Hollenberg, NK (2006) Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47, Suppl. 2, S210–S214.
52.Dinges, DF (2006) Cocoa flavanols, cerebral blood flow, cognition, and health: going forward. J Cardiovasc Pharmacol 47, Suppl. 2, S221–S223.
53.Gage, FH (2000) Mammalian neural stem cells. Science 287, 1433–1438.
54.Palmer, TD, Willhoite, AR & Gage, FH (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425, 479–494.
55.Harris, KM & Kater, SB (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 17, 341–371.
56.van Praag, H, Lucero, MJ, Yeo, GW et al. (2007) Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 27, 5869–5878.
57.Joseph, JA, Shukitt-Hale, B, Denisova, NA, Prior, RL, Cao, G, Martin, A, Taglialatela, G & Bickford, PC (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18, 8047–8055.
58.Joseph, JA, Shukitt-Hale, B, Denisova, NA, Bielinski, D, Martin, A, McEwen, JJ & Bickford, PC (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114–8121.
59.Casadesus, G, Shukitt-Hale, B, Stellwagen, HM, Zhu, X, Lee, HG, Smith, MA & Joseph, JA (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309–316.
60.Shukitt-Hale, B, Smith, DE, Meydani, M & Joseph, JA (1999) The effects of dietary antioxidants on psychomotor performance in aged mice. Exp Gerontol 34, 797–808.
61.Joseph, JA, Shukitt-Hale, B & Casadesus, G (2005) Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 81, 313S–316S.
62.Goyarzu, P, Malin, DH, Lau, FC et al. (2004) Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 7, 75–83.
63.Joseph, JA, Denisova, NA, Arendash, G, Gordon, M, Diamond, D, Shukitt-Hale, B & Morgan, D (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153–162.
64.Andres-Lacueva, C, Shukitt-Hale, B, Galli, RL, Jauregui, O, Lamuela-Raventos, RM & Joseph, JA (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8, 111–120.
65.Ramirez, MR, Izquierdo, I, do Carmo Bassols, RM, Zuanazzi, JA, Barros, D & Henriques, AT (2005) Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52, 457–462.
66.Chan, YC, Hosoda, K, Tsai, CJ, Yamamoto, S & Wang, MF (2006) Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. J Nutr Sci Vitaminol (Tokyo) 52, 266–273.
67.Shukitt-Hale, B, Carey, A, Simon, L, Mark, DA & Joseph, JA (2006) Effects of Concord grape juice on cognitive and motor deficits in aging. Nutrition 22, 295–302.
68.Singh, A, Naidu, PS & Kulkarni, SK (2003) Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid. Free Radic Res 37, 1245–1252.
69.Patil, CS, Singh, VP, Satyanarayan, PS, Jain, NK, Singh, A & Kulkarni, SK (2003) Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 69, 59–67.
70.Wang, H, Hu, Y & Tsien, JZ (2006) Molecular and systems mechanisms of memory consolidation and storage. Prog Neurobiol 79, 123–135.
71.Squire, LR & Zola-Morgan, S (1991) The medial temporal lobe memory system. Science 253, 1380–1386.
72.Squire, LR (2004) Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 82, 171–177.
73.Squire, LR, Stark, CE & Clark, RE (2004) The medial temporal lobe. Annu Rev Neurosci 27, 279–306.
74.Alvarez, P & Squire, LR (1994) Memory consolidation and the medial temporal lobe: a simple network model. Proc Natl Acad Sci USA 91, 7041–7045.
75.Anagnostaras, SG, Maren, S & Fanselow, MS (1999) Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. J Neurosci 19, 1106–1114.
76.Zola-Morgan, SM & Squire, LR (1990) The primate hippocampal formation: evidence for a time-limited role in memory storage. Science 250, 288–290.
77.Squire, LR & Alvarez, P (1995) Retrograde amnesia and memory consolidation: a neurobiological perspective. Curr Opin Neurobiol 5, 169–177.
78.Weeber, EJ & Sweatt, JD (2002) Molecular neurobiology of human cognition. Neuron 33, 845–848.
79.Dash, PK, Moore, AN, Kobori, N & Runyan, JD (2007) Molecular activity underlying working memory. Learn Mem 14, 554–563.
80.Tully, T (1998) Toward a molecular biology of memory: the light's coming on! Nat Neurosci 1, 543–545.
81.Carew, TJ (1996) Molecular enhancement of memory formation. Neuron 16, 5–8.
82.Bramham, CR & Wells, DG (2007) Dendritic mRNA: transport, translation and function. Nat Rev Neurosci 8, 776–789.
83.Martin, KC, Barad, M & Kandel, ER (2000) Local protein synthesis and its role in synapse-specific plasticity. Curr Opin Neurobiol 10, 587–592.
84.Kelleher, RJ III, Govindarajan, A & Tonegawa, S (2004) Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44, 59–73.
85.Arnsten, AF, Ramos, BP, Birnbaum, SG & Taylor, JR (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11, 121–128.
86.van der Heide, LP, Ramakers, GM & Smidt, MP (2006) Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 79, 205–221.
87.Alkon, DL, Sun, MK & Nelson, TJ (2007) PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol Sci 28, 51–60.
88.Wei, F, Qiu, CS, Liauw, J, Robinson, DA, Ho, N, Chatila, T & Zhuo, M (2002) Calcium calmodulin-dependent protein kinase IV is required for fear memory. Nat Neurosci 5, 573–579.
89.Sweatt, JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76, 1–10.
90.Sweatt, JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14, 311–317.
91.Impey, S, McCorkle, SR, Cha-Molstad, H, Dwyer, JM, Yochum, GS, Boss, JM, McWeeney, S, Dunn, JJ, Mandel, G & Goodman, RH (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041–1054.
92.Barco, A, Bailey, CH & Kandel, ER (2006) Common molecular mechanisms in explicit and implicit memory. J Neurochem 97, 1520–1533.
93.Bourtchuladze, R, Frenguelli, B, Blendy, J, Cioffi, D, Schutz, G & Silva, AJ (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59–68.
94.Tully, T, Bourtchouladze, R, Scott, R & Tallman, J (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2, 267–277.
95.Pham, TA, Impey, S, Storm, DR & Stryker, MP (1999) CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron 22, 63–72.
96.Impey, S, Smith, DM, Obrietan, K, Donahue, R, Wade, C & Storm, DR (1998) Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1, 595–601.
97.Impey, S, Mark, M, Villacres, EC, Poser, S, Chavkin, C & Storm, DR (1996) Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 16, 973–982.
98.Finkbeiner, S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25, 11–14.
99.Finkbeiner, S, Tavazoie, SF, Maloratsky, A, Jacobs, KM, Harris, KM & Greenberg, ME (1997) CREB: a major mediator of neuronal neurotrophin responses. Neuron 19, 1031–1047.
100.Abbott, NJ (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200, 629–638.
101.Youdim, KA, Dobbie, MS, Kuhnle, G, Proteggente, AR, Abbott, NJ & Rice-Evans, C (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85, 180–192.
102.Youdim, KA, Shukitt-Hale, B & Joseph, JA (2004) Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37, 1683–1693.
103.Youdim, KA, Qaiser, MZ, Begley, DJ, Rice-Evans, CA & Abbott, NJ (2004) Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36, 592–604.
104.Aasmundstad, TA, Morland, J & Paulsen, RE (1995) Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 275, 435–441.
105.Sperker, B, Backman, JT & Kroemer, HK (1997) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33, 18–31.
106.Kroemer, HK & Klotz, U (1992) Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23, 292–310.
107.Lin, JH & Yamazaki, M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42, 59–98.
108.Suganuma, M, Okabe, S, Oniyama, M, Tada, Y, Ito, H & Fujiki, H (1998) Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771–1776.
109.Abd El Mohsen, MM, Kuhnle, G, Rechner, AR, Schroeter, H, Rose, S, Jenner, P & Rice-Evans, CA (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693–1702.
110.Talavera, S, Felgines, C, Texier, O, Besson, C, Gil-Izquierdo, A, Lamaison, JL & Remesy, C (2005) Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 53, 3902–3908.
111.Abd El Mohsen, MM, Marks, J, Kuhnle, G, Moore, K, Debnam, E, Kaila, SS, Rice-Evans, C & Spencer, JPE (2006) Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 95, 51–58.
112.Halliwell, B, Zhao, K & Whiteman, M (2000) The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 33, 819–830.
113.Vauzour, D, Vafeiadou, K, Corona, G, Pollard, SE, Tzounis, X & Spencer, JPE (2007) Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury. J Agric Food Chem 55, 2854–2860.
114.Vafeiadou, K, Vauzour, D & Spencer, JPE (2007) Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 7, 211–224.
115.Matter, WF, Brown, RF & Vlahos, CJ (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186, 624–631.
116.Vlahos, CJ, Matter, WF, Hui, KY & Brown, RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269, 5241–5248.
117.Agullo, G, Gamet-Payrastre, L, Manenti, S, Viala, C, Remesy, C, Chap, H & Payrastre, B (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649–1657.
118.Gamet-Payrastre, L, Manenti, S, Gratacap, MP, Tulliez, J, Chap, H & Payrastre, B (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 32, 279–286.
119.Kong, AN, Yu, R, Chen, C, Mandlekar, S & Primiano, T (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 23, 1–16.
120.Schroeter, H, Spencer, JPE, Rice-Evans, C & Williams, RJ (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358, 547–557.
121.Spencer, JPE (2007) The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2, 257–273.
122.Conseil, G, Baubichon-Cortay, H, Dayan, G, Jault, JM, Barron, D & Di Pietro, A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95, 9831–9836.
123.Di Pietro, A, Godinot, C, Bouillant, ML & Gautheron, DC (1975) Pig heart mitochondrial ATPase: properties of purified and membrane-bound enzyme. Effects of flavonoids. Biochimie 57, 959–967.
124.Barzilai, A & Rahamimoff, H (1983) Inhibition of Ca2+-transport ATPase from synaptosomal vesicles by flavonoids. Biochim Biophys Acta 730, 245–254.
125.Revuelta, MP, Cantabrana, B & Hidalgo, A (1997) Depolarization-dependent effect of flavonoids in rat uterine smooth muscle contraction elicited by CaCl2. Gen Pharmacol 29, 847–857.
126.Lee, SF & Lin, JK (1997) Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 28, 177–183.
127.Ursini, F, Maiorino, M, Morazzoni, P, Roveri, A & Pifferi, G (1994) A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Radic Biol Med 16, 547–553.
128.Kantengwa, S & Polla, BS (1991) Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 180, 308–314.
129.Rosenblat, M, Belinky, P, Vaya, J, Levy, R, Hayek, T, Coleman, R, Merchav, S & Aviram, M (1999) Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J Biol Chem 274, 13790–13799.
130.Boege, F, Straub, T, Kehr, A, Boesenberg, C, Christiansen, K, Andersen, A, Jakob, F & Kohrle, J (1996) Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271, 2262–2270.
131.Medina, JH, Viola, H, Wolfman, C, Marder, M, Wasowski, C, Calvo, D & Paladini, AC (1997) Overview – Flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 22, 419–425.
132.Dekermendjian, K, Kahnberg, P, Witt, MR, Sterner, O, Nielsen, M & Liljefors, T (1999) Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J Med Chem 42, 4343–4350.
133.Fischer, PM & Lane, DP (2000) Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem 7, 1213–1245.
134.Huang, YT, Hwang, JJ, Lee, PP, Ke, FC, Huang, JH, Huang, CJ, Kandaswami, C, Middleton, E Jr & Lee, MT (1999) Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128, 999–1010.
135.So, FV, Guthrie, N, Chambers, AF, Moussa, M & Carroll, KK (1996) Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 26, 167–181.
136.Green, DR & Reed, JC (1998) Mitochondria and apoptosis. Science 281, 1309–1312.
137.Tatton, WG & Olanow, CW (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta 1410, 195–213.
138.Goyal, L (2001) Cell death inhibition: keeping caspases in check. Cell 104, 805–808.
139.Srinivasula, SM, Hegde, R, Saleh, A et al. (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410, 112–116.
140.Schroeter, H, Bahia, P, Spencer, JPE, Sheppard, O, Rattray, M, Rice-Evans, C & Williams, RJ (2007) (-)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J Neurochem 101, 1596–1606.
141.Maher, P, Akaishi, T & Abe, K (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 103, 16568–16573.
142.Vauzour, D, Vafeiadou, K, Rice-Evans, C, Williams, RJ & Spencer, JPE (2007) Activation of pro-survival Akt and ERK1/2 signaling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103, 1355–1367.
143.Levites, Y, Amit, T, Youdim, MB & Mandel, S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277, 30574–30580.
144.Reznichenko, L, Amit, T, Youdim, MB & Mandel, S (2005) Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 1157–1167.
145.Pollard, SE, Whiteman, M & Spencer, JPE (2006) Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signalling. Biochem Biophys Res Commun 347, 916–923.
146.Walker, EH, Pacold, ME, Perisic, O, Stephens, L, Hawkins, PT, Wymann, MP & Williams, RL (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6, 909–919.
147.Jacobson, KA, Moro, S, Manthey, JA, West, PL & Ji, XD (2002) Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol 505, 163–171.
148.Johnston, GA (2005) GABA(A) receptor channel pharmacology. Curr Pharm Des 11, 1867–1885.
149.Adachi, N, Tomonaga, S, Tachibana, T, Denbow, DM & Furuse, M (2006) (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531, 171–175.
150.Han, YS, Bastianetto, S, Dumont, Y & Quirion, R (2006) Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318, 238–245.
151.Nifli, AP, Bosson-Kouame, A, Papadopoulou, N, Kogia, C, Kampa, M, Castagnino, C, Stournaras, C, Vercauteren, J & Castanas, E (2005) Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp Cell Res 309, 329–339.
152.Klinge, CM, Blankenship, KA, Risinger, KE, Bhatnagar, S, Noisin, EL, Sumanasekera, WK, Zhao, L, Brey, DM & Keynton, RS (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280, 7460–7468.
153.Conkright, MD, Guzman, E, Flechner, L, Su, AI, Hogenesch, JB & Montminy, M (2003) Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11, 1101–1108.
154.Tao, X, Finkbeiner, S, Arnold, DB, Shaywitz, AJ & Greenberg, ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726.
155.Shieh, PB, Hu, SC, Bobb, K, Timmusk, T & Ghosh, A (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727–740.
156.Bramham, CR & Messaoudi, E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76, 99–125.
157.Patterson, SL, Grover, LM, Schwartzkroin, PA & Bothwell, M (1992) Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF & NT-3 mRNAs. Neuron 9, 1081–1088.
158.Thomas, K & Davies, A (2005) Neurotrophins: a ticket to ride for BDNF. Curr Biol 15, R262–R264.
159.Peng, S, Wuu, J, Mufson, EJ & Fahnestock, M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93, 1412–1421.
160.Michalski, B & Fahnestock, M (2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 111, 148–154.
161.Egan, MF, Kojima, M, Callicott, JH et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
162.Linnarsson, S, Bjorklund, A & Ernfors, P (1997) Learning deficit in BDNF mutant mice. Eur J Neurosci 9, 2581–2587.
163.Mu, JS, Li, WP, Yao, ZB & Zhou, XF (1999) Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835, 259–265.
164.Minichiello, L, Korte, M, Wolfer, D, Kuhn, R, Unsicker, K, Cestari, V, Rossi-Arnaud, C, Lipp, HP, Bonhoeffer, T & Klein, R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401–414.
165.Wullschleger, S, Loewith, R & Hall, MN (2006) TOR signaling in growth and metabolism. Cell 124, 471–484.
166.Ferriola, PC, Cody, V & Middleton, E Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38, 1617–1624.
167.Schratt, GM, Nigh, EA, Chen, WG, Hu, L & Greenberg, ME (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neurosci 24, 7366–7377.
168.Yin, Y, Edelman, GM & Vanderklish, PW (2002) The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proc Natl Acad Sci USA 99, 2368–2373.
169.Waltereit, R, Dammermann, B, Wulff, P, Scafidi, J, Staubli, U, Kauselmann, G, Bundman, M & Kuhl, D (2001) Arg3.1/Arc mRNA induction by Ca2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation. J Neurosci 21, 5484–5493.
170.Soule, J, Messaoudi, E & Bramham, CR (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans 34, 600–604.
171.Lyford, GL, Yamagata, K, Kaufmann, WE, Barnes, CA, Sanders, LK, Copeland, NG, Gilbert, DJ, Jenkins, NA, Lanahan, AA & Worley, PF (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433–445.
172.Reznichenko, L, Amit, T, Youdim, MB & Mandel, S (2005) Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 1157–1167.